Symbol: |
CDCA7L
|
Description: |
cell division cycle associated 7-like [Source:HGNC Symbol;Acc:30777]
|
Location: |
Chr7:21940518-21985702[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:203
Gene |
Compound |
Gen_sig |
Exp_pattern |
CDCA7L |
Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-propylamino}ethane Bis(trifluoroacetate |
0.003 |
Down |
CDCA7L |
1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one |
0.026 |
Down |
CDCA7L |
6-(3-Aminopropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo- 3-nitro-11H-indeno[1,2-c]isoquinoline Hydrochloride Salt |
0.004 |
Down |
CDCA7L |
Dasatinib |
0.048 |
Up |
CDCA7L |
Everolimus |
0.006 |
Up |
CDCA7L |
gamma-glutamyl-alpha-amino-beta-[[2-ethyl(5-fluoro-2'deoxyur idyl) N-methyl-N-(4-chlorobutyl)phosphoramidoyl]sulfonyl] propionyl-(R)-(-)-phenylglycine |
0.027 |
Down |
CDCA7L |
NSC 734631 |
0.011 |
Down |
CDCA7L |
NSC 735333 |
0.014 |
Up |
CDCA7L |
NSC 736021 |
0.026 |
Up |
CDCA7L |
NSC 736154 |
0.024 |
Down |
CDCA7L |
6-(3-Aminopropyl)-5,6-dihyro-9-iodo-3-nitro-5,11-dioxo-11H-i ndeno[1,2-c]isoquinoline Hydrochloride |
0.006 |
Down |
CDCA7L |
6-(3-Aminopropyl)-5,6-dihydro-3-nitro-5,11-dioxo-9-thiomethy l-11H-indeno[1,2-c]isoquinoline Hydrochloride |
0.001 |
Down |
CDCA7L |
6-(3-Chloropropyl)-5,6-dihydro-2,3,9-trimethoxy-5,11-dioxo-1 1H-indeno[1,2-c]isoquinoline |
0.009 |
Down |
CDCA7L |
ULEINE |
0.044 |
Up |
CDCA7L |
8-Chloro-3-(2-hydroxyphenyl)-2-methyl-5,5-dioxo-2,3-dihydro- [1,2,4]triazolo[4,3-b][1,4,2]benzodithiazine |
0.035 |
Down |
Expression pattern: Sensitivity / Resistance
Total:14 Current:13
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:65
Total:5 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:17
Total:2 Current:1
[First] [Prev]  Next Last 
|